<p>BridgeBio Pharma 今天獲得了花旗分析師的持有評級和目標價。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者精選</li>
</ul>
<p>除了花旗，BridgeBio Pharma 還在今天的報告中獲得了摩根大通的 Eric Joseph 的持有評級。然而，在 5 月 13 日，美國銀行證券重申了對 BridgeBio Pharma (NASDAQ: BBIO) 的買入評級。</p>

BBIO

標普全球醫療股指數 ETF - iShares

動態生物技術與基因組 ETF - Invesco

<p>BridgeBio Pharma 今天獲得了花旗分析師的持有評級和目標價。聲明享受 55% 的折扣 TipRanks 解鎖對沖基金級別的數據和強大的投資工具，以便做出更聰明、更精準的決策。發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者精選。此外，BridgeBio Pharma 還在今天的報告中獲得了摩根大通的 Eric Joseph 的持有評級。然而，在 5 月 13 日，美國銀行證券重申了對 BridgeBio Pharma (NASDAQ: BBIO) 的買入評級</p>

<p>BridgeBio Pharma received a Hold rating and price target from Citi analyst today.</p>
<div class="lb-trans"><p>BridgeBio Pharma 今天獲得了花旗分析師的持有評級和目標價。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者精選</li>
</ul>
</div><p>In addition to Citi, BridgeBio Pharma also received a Hold from J.P. Morgan’s Eric Joseph in a report issued today. However, on May 13, Bank of America Securities reiterated a Buy rating on BridgeBio Pharma (NASDAQ: BBIO).</p>
<div class="lb-trans"><p>除了花旗，BridgeBio Pharma 還在今天的報告中獲得了摩根大通的 Eric Joseph 的持有評級。然而，在 5 月 13 日，美國銀行證券重申了對 BridgeBio Pharma (NASDAQ: BBIO) 的買入評級。</p>
</div>

BridgeBio Pharma (BBIO) Gets a Hold from Citi

Tip Ranks

Bridgebio Pharma

標普生物技術 3 倍做多 - Direxion

標普生物技術 ETF - SPDR

基因改革 ETF - ARK

生物科技 ETF - VanEck Vectors

紐交所高增長板生物技術指數 ETF - First Trust

美國制藥 ETF - iShares

醫療業 ETF - Vanguard

2 倍做多納斯達克生物技術 ETF - ProShares

標普生物技術 3 倍做空 - Direxion

納斯達克生物科技指數 ETF - iShares Nasdaq

醫藥突破 ETF - ALPS

醫療業 ETF - SPDR

花旗

摩根大通

美國銀行

CITIGROUP INC 6.250 NON CUM SER II PFD WI

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

BridgeBio Pharma (BBIO) 被花旗給予持有評級